Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia. 2020 Oct;34(10):2820. doi: 10.1038/s41375-020-0994-7.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum